The endemicity of an area in terms of micronutrient deficiencies as a criterion for compounding a basic vitamin-mineral complex for the periconceptional period


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The authors have carried out a systems analysis of the data available in the current literature on the effect of micronutrients, such as iodine, polyunsaturated fatty acids, folic acid, and vitamin D, on a woman’s reproductive health. Due to its geographical location, climatic features, and eating habits, our country has the proven deficiency of a number of micronutrients that play an important role in the periconceptional period. These micronutrients include iodine, polyunsaturated fatty acids, folic acid, and vitamin D. The content of micronutrients should not exceed the physiological daily requirement in the basic complexes intended for the prevention of deficiency, The excessive content of components can cause undesirable reactions and contribute to the allergization of newborns. In clinically pronounced deficiency, the basal complex can be combined with a monocomponent vitamin preparation for the targeted correction of vitamin and mineral status.

Full Text

Restricted Access

About the authors

Evgenia V. Shikh

I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: chih@mail.ru
MD, Professor, Head of the Department of Clinical Pharmacology and Propedeutics of Internal Diseases

Anna A. Makhova

I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia

Email: annabramova@gmail.com
PhD, Associate Professor of the Department of Clinical Pharmacology and Propaedeutics of Internal Diseases

References

  1. Lowensohn R.I., Stadler D.D., Naze C. Current concepts of maternal nutrition. Obstet. Gynecol. Surv. 2016; 71(7): 413-26.
  2. Ших Е.В., Махова А.А. Витаминно-минеральный комплекс при беременности. М.: ГЭОТАР-Медиа; 2016. 349с.
  3. Серов В.Н., Торшин И.Ю., Громова О.А. Потриместровый подход к назначению витаминно-минеральных комплексов на основе систематического анализа биологической значимости витаминов и микроэлементов в системе мать-плацента-плод. Гинекология. 2010; 12(6): 24-34.
  4. Burton G.J., Jauniaux E., Charnock-Jones D.S. Human early placental development: potential roles of the endometrial glands. Placenta. 2007;28(Suppl. A): S64-9.
  5. Barker D.J., Thornburg K.L. Placental programming of chronic diseases, cancer and lifespan: a review. Placenta. 2013; 34(10): 841-5.
  6. Ших Е.В., Ильенко Л.И. Клинико-фармакологические аспекты применения витаминно-минеральных комплексов в педиатрии. Учебное пособие. М.: Медпрактика-М; 2008.
  7. Crider K.S., Bailey L.B., Berry R.J. Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients. 2011; 3(3): 370-84.
  8. Chang H., Zhang T., Zhang Z., Bao R., Fu C., Wang Z. et al. Tissue-specific distribution of aberrant DNA methylation associated with maternal low-folate status in human neural tube defects. J. Nutr. Biochem. 2011; 22(12): 1172-7.
  9. Chiaffarino F., Ascone G.B., Bortolus R., Mastroia-Covo P., Ricci E., Cipriani S., Parazzini F. Effects of folic acid supplementation on pregnancy outcomes: a review of randomized clinical trials. Minerva Ginecol. 2010; 62(4): 293-301.
  10. Shaw G.M., Carmichael S.L., Yang W., Siega-Riz A.M.; National Birth Defects Prevention Study. Periconceptional intake of folic acid and food folate and risks of preterm delivery. Am. J. Perinatol. 2011; 28(10): 747-52.
  11. Surén P., Roth C., Bresnahan M., Haugen M., Hornig M., Hirtz D. et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013; 309(6): 570-7.
  12. WHO. Guideline: Daily iron and folic acid supplementation in pregnant women. Geneva: World Health Organization; 2012.
  13. Jagerstad M. Folic acid fortification prevents neural tube defects and may also reduce cancer risks. Acta Paediatr. 2012; 101(10): 1007-12.
  14. Нормы физиологической потребности в витамине В9 в зависимости от возраста в России. Available at: http://docs.cntd.ru/document/1200076084
  15. Shin J.S., Choi M.Y., Longtine M.S., Nelson D.M. Vitamin D. effects on pregnancy and the placenta. Placenta. 2010; 31(12): 1027-34.
  16. Brannon P.M., Picciano M.F. Vitamin D. in pregnancy and lactation in humans. Annu. Rev. Nutr. 2011; 31: 89-115.
  17. Thorne-Lyman A., Fawzi W.W. Vitamin D. during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr. Perinat. Epidemiol. 2012; 26(1): 10.
  18. Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Сидельникова В.М. Нутрициальный подход к профилактике избыточной массы тела новорожденных. Гинекология. 2010; 12(5): 56-64.
  19. Maghbooli Z., Hossein-Nezhad A., Karimi F., Shafaei A.R., Larijani B. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab. Res. Rev. 2008; 24(1): 27-32.
  20. Haugen M., Brantsaeter A.L., Trogstad L., Alexander J., Roth C., Magnus P. et al. Vitamin D. supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology. 2009; 20(5): 720-6.
  21. Merewood A., Mehta S.D., Chen T.C., Bauchner H., Holick M.F. Association between vitamin D. deficiency and primary cesarean section. J. Clin. Endocrinol. Metab. 2009; 94(3): 940-5.
  22. WHO. Guideline: Vitamin D. supplementation in pregnant women. Geneva: World Health Organization; 2012: 3-5.
  23. Нормы физиологических потребностей в энергии и пищевых веществах для различных групп населения Российской Федерации. Методические рекомендации МР 2.3.1.2432-08. М.; 2009.
  24. Williams G.R. Neurodevelopmental and neurophysiological actions of thyroid hormones. J. Neuroendocrinol. 2008; 20(6): 784-94.
  25. Кочергина И.И. Профилактика и лечение дефицита йода и эндемического зоба. Русский медицинский журнал. 2009; 24(363): 1599.
  26. Stagnaro-Green A., Sullivan S., Pearce E.N. Iodine supplementation during pregnancy and lactation. JAMA. 2012; 308(23): 2463-4.
  27. Zimmermann M.B. Iodine and iodine deficiency disorders. In: Erdman J.W.J., Macdonald I.A., Zeisel S.H., eds. Present knowledge in nutrition. 10th ed. Washington, D.C.: Wiley-Blackwell; 2012: 554-67.
  28. Connelly K.J., Boston B.A., Pearce E.N., Sesser D., Snyder D., Braverman L.E. et al. Congenital hypothyroidism caused by excess prenatal maternal iodine ingestion. J. Pediatr. 2012; 161(4): 760-2.
  29. Flock M.R., Skulas-Ray A.C., Harris W.S., Etherton T.D., Fleming J.A., Kris-Etherton P.M. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J. Am. Heart Assoc. 2013; 2(6): e000513.
  30. Davidson P.W., Strain J.J., Myers G.J., Thurston S.W., Bonham M.P., Shamlaye C.F. et al. Neurodevelopmental effects of maternal nutritional status and exposure to methylmercury from eating fish during pregnancy. Neurotoxicology. 2008; 29(5): 767-75.
  31. Лиманова О.А., Громова О.А., Торшин И.Ю., Волков А.Ю., Галустян А.Н., Гришина Т.Р., Керимкулова Н.В., Сардарян И.С., Сонина Н.П., Томилова И.К., Федотова Л.Э. Низкое потребление омега-3 полиненасыщенных жирных кислот и риск различных заболеваний у женщин репродуктивного возраста. РМЖ. 2018; 5(I). Доступно: https://www.rmj. ru/articles/ginekologiya/nizkoe-potreblenie-omega-3-polinenasyshchennykh-zhirnykh-kislot-i-risk-razlichnykh-zabolevaniy-u-zhe/
  32. Hadders-Algra M. Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J. Perinat. Med. 2008; 36(2): 101-9.
  33. Davidson M.H. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Curr. Opin. Lipidol. 2013; 24(6): 467-74.
  34. Yazdi P.G. A review of the biologic and pharmacological role of docosapentaenoic acid [version 1; referees: 2 approved with reservations]. F1000Research. 2013, 2: 256.
  35. Cherhan C.N. Novel lipid mediators and resolutionmechanism in acute inflammationю Am. J. Pathol. 2010; 177(4): 1576-91.
  36. Куликов В.А., Гребенников В.Н. Резольвины, протектины и марезины - новые медиаторы воспаления. Вестник Витебского государственного медицинского университета. 2012; 11(1): 25-30.
  37. See V.H.L., Mas E., Prescott S.L., Beilin L.J., Burrows S., Barden A.E. et al. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial. Br. J. Nutr. 2017; 118(11): 971-80.
  38. Ганчар Е.П., Кажина М.В., Яговдик И.Н. Клиническая значимость омега-3 полиненасыщенных жирных кислот в акушерстве (обзор литературы). Журнал Гродненского государственного медицинского университета. 2012; 2: 7-10.
  39. Guesnet P., Alessandri J.M. Docosahexaenoic acid (DHA) and the developing central nervous system (CNS) - Implications for dietary recommendations. Biochimie. 2011; 93(1): 7-12.
  40. European Food Safety Authority. Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA J. 2010;8(3):1-107. Available at: http://www.efsa.europa.eu
  41. Rizos E.C., Ntzani E.E., Bika E., Kostapanos M.S., Elisaf M.S. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA. 2012; 308(10): 1024-33.
  42. Traber M.G. Vitamin E. In: Erdman JWJ, Macdonald IA, Zeisel SH, eds. Present knowledge in nutrition. 10th ed. Washington, D.C.: Wiley-Blackwell; 2012: 214-29.
  43. Boskovic R.L., Gargaun L., Oren D., Djulus J., Koren G. Pregnancy outcome following high doses of Vitamin E. supplementation. Reprod Toxicol. 2005; 20(1): 85-8.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2018 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies